Deep Visual Proteomics defines single-cell identity and heterogeneity

Andreas Mund(University of Copenhagen), Fabian Coscia(University of Copenhagen), András Kriston(HUN-REN Szegedi Biológiai Kutatóközpont), Réka Hollandi(HUN-REN Szegedi Biológiai Kutatóközpont), Ferenc Kovács(HUN-REN Szegedi Biológiai Kutatóközpont), Andreas‐David Brunner(Max Planck Institute of Biochemistry), Ede Migh(HUN-REN Szegedi Biológiai Kutatóközpont), Lisa Schweizer(Max Planck Institute of Biochemistry), Alberto Santos(University of Copenhagen), Michael Bzorek(Zealand University Hospital), Soraya Naimy(Zealand University Hospital), Lise Mette Rahbek Gjerdrum(University of Copenhagen), Beatrice Dyring‐Andersen(University of Copenhagen), Jutta Bulkescher(University of Copenhagen), Claudia Lukas(University of Copenhagen), Mark A. Eckert(University of Chicago), Ernst Lengyel(University of Chicago), Christian Gnann(Science for Life Laboratory), Emma Lundberg(Science for Life Laboratory), Péter Horváth(University of Helsinki), Matthias Mann(University of Copenhagen)
Nature Biotechnology
May 19, 2022
Cited by 525Open Access
Full Text

Abstract

Despite the availabilty of imaging-based and mass-spectrometry-based methods for spatial proteomics, a key challenge remains connecting images with single-cell-resolution protein abundance measurements. Here, we introduce Deep Visual Proteomics (DVP), which combines artificial-intelligence-driven image analysis of cellular phenotypes with automated single-cell or single-nucleus laser microdissection and ultra-high-sensitivity mass spectrometry. DVP links protein abundance to complex cellular or subcellular phenotypes while preserving spatial context. By individually excising nuclei from cell culture, we classified distinct cell states with proteomic profiles defined by known and uncharacterized proteins. In an archived primary melanoma tissue, DVP identified spatially resolved proteome changes as normal melanocytes transition to fully invasive melanoma, revealing pathways that change in a spatial manner as cancer progresses, such as mRNA splicing dysregulation in metastatic vertical growth that coincides with reduced interferon signaling and antigen presentation. The ability of DVP to retain precise spatial proteomic information in the tissue context has implications for the molecular profiling of clinical samples.


Related Papers

No related papers found

Powered by citation graph analysis